2
PharmEasy's scale reaches Rs 5,700 Cr in FY22, losses increase fourfold
source link: https://nextbigwhat.com/pharmeasys-scale-reaches-rs-5700-cr-in-fy22-losses-increase-fourfold/
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
PharmEasy’s scale reaches Rs 5,700 Cr in FY22, losses increase fourfold
• API Holdings, the parent company of online drug dispenser PharmEasy, has faced a difficult year in 2022.
• The firm had to put its initial public offering (IPO) plans on hold due to market conditions.
• PharmEasy is now looking to raise funds with a potential 25% haircut from its peak $5.1 billion valuation.
• Despite this, PharmEasy’s scale has reached Rs 5,700 Cr in FY22.
• Losses have increased fourfold.
Download NBW App: Short tech news app for busy professionals. Save time. Move forward. (Android, iOS)
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK